{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:09:30Z","timestamp":1790726970290,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-26316-5","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:36:27Z","timestamp":1769045787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic value of non-invasive fibrosis assessment scores in predicting mortality among individuals with metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Lingjie","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunling","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"26316_CR1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","volume":"55","author":"J Ludwig","year":"1980","unstructured":"Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434\u20138.","journal-title":"Mayo Clin Proc"},{"key":"26316_CR2","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78:1966\u201386.","journal-title":"Hepatology"},{"key":"26316_CR3","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31:S32\u201350.","journal-title":"Clin Mol Hepatol"},{"key":"26316_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Keach JC, Lafferty HD, Stahler A, et al. Liver Fibrosis, but no other histologic Features, is associated with Long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149:389\u2013e397310.","journal-title":"Gastroenterology"},{"key":"26316_CR5","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.3350\/cmh.2024.0246","volume":"31","author":"Y Wang","year":"2025","unstructured":"Wang Y, Song SJ, Jiang Y, Lai JC, Wong GL, Wong VW, Yip TC. Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31:S51\u201375.","journal-title":"Clin Mol Hepatol"},{"key":"26316_CR6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.3350\/cmh.2025.0045","volume":"31","author":"W Sohn","year":"2025","unstructured":"Sohn W, Lee YS, Kim SS, Kim JH, Jin YJ, Kim GA, Sung PS, Yoo JJ, Chang Y, Lee EJ, et al. KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025. Clin Mol Hepatol. 2025;31:S1\u201331.","journal-title":"Clin Mol Hepatol"},{"key":"26316_CR7","doi-asserted-by":"publisher","first-page":"107147","DOI":"10.1016\/j.rmed.2023.107147","volume":"209","author":"W Gu","year":"2023","unstructured":"Gu W, Tian Z, Tian W, Song Y, Qi G, Qi J, Sun C. Association of rest-activity circadian rhythm with chronic respiratory diseases, a cross-section survey from NHANES 2011\u20132014. Respir Med. 2023;209:107147.","journal-title":"Respir Med"},{"key":"26316_CR8","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846\u201354.","journal-title":"Hepatology"},{"key":"26316_CR9","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Torriani MSS, Dieterich FJ, Thomas DT. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43:1317\u201325.","journal-title":"Hepatology"},{"key":"26316_CR10","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gut.2007.146019","volume":"57","author":"SA Harrison","year":"2008","unstructured":"Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57:1441\u20137.","journal-title":"Gut"},{"key":"26316_CR11","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jhep.2016.01.009","volume":"64","author":"P Udompap","year":"2016","unstructured":"Udompap P, Mannalithara A, Heo NY, Kim D, Kim WR. Increasing prevalence of cirrhosis among U.S. Adults aware or unaware of their chronic hepatitis C virus infection. J Hepatol. 2016;64:1027\u201332.","journal-title":"J Hepatol"},{"key":"26316_CR12","first-page":"e14477","volume":"13","author":"T Bukhari","year":"2021","unstructured":"Bukhari T, Jafri L, Majid H, Ahmed S, Khan AHH, Abid S, Raza A, Siddiqui I. Diagnostic accuracy of the forns score for liver cirrhosis in patients with chronic viral hepatitis. Cureus. 2021;13:e14477.","journal-title":"Cureus"},{"key":"26316_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, Kim YJ, Yoon JH, Cho SH, Sung MW, Lee HS. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42:503\u20138.","journal-title":"Dig Liver Dis"},{"key":"26316_CR14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","volume":"137","author":"A Kotronen","year":"2009","unstructured":"Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, Johansson LM, Lundbom N, Rissanen A, Ridderstr\u00e5le M, Groop L, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology. 2009;137:865\u201372.","journal-title":"Gastroenterology"},{"key":"26316_CR15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/hep.32545","volume":"77","author":"P Sripongpun","year":"2023","unstructured":"Sripongpun P, Kim WR, Mannalithara A, Charu V, Vidovszky A, Asch S, Desai M, Kim SH, Kwong AJ. The steatosis-associated fibrosis estimator (SAFE) score: A tool to detect low-risk NAFLD in primary care. Hepatology. 2023;77:256\u201367.","journal-title":"Hepatology"},{"key":"26316_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1053\/j.gastro.2024.03.017","volume":"167","author":"LA van Kleef","year":"2024","unstructured":"van Kleef LA, Francque SM, Prieto-Ortiz JE, Sonneveld MJ, Sanchez-Luque CB, Prieto-Ortiz RG, Kwanten WJ, Vonghia L, Verrijken A, De Block C, et al. Metabolic dysfunction-Associated fibrosis 5 (MAF-5) score predicts liver fibrosis risk and outcome in the general population with metabolic dysfunction. Gastroenterology. 2024;167:357\u2013e367359.","journal-title":"Gastroenterology"},{"key":"26316_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/apt.13012","volume":"41","author":"CE Ruhl","year":"2015","unstructured":"Ruhl CE, Everhart JE. Fatty liver indices in the multiethnic united States National health and nutrition examination survey. Aliment Pharmacol Ther. 2015;41:65\u201376.","journal-title":"Aliment Pharmacol Ther"},{"key":"26316_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/ajcn\/88.2.324","volume":"88","author":"AJ Moshfegh","year":"2008","unstructured":"Moshfegh AJ, Rhodes DG, Baer DJ, Murayi T, Clemens JC, Rumpler WV, Paul DR, Sebastian RS, Kuczynski KJ, Ingwersen LA, et al. The US department of agriculture automated Multiple-Pass method reduces bias in the collection of energy intakes. Am J Clin Nutr. 2008;88:324\u201332.","journal-title":"Am J Clin Nutr"},{"key":"26316_CR19","doi-asserted-by":"publisher","first-page":"1140160","DOI":"10.3389\/fcvm.2023.1140160","volume":"10","author":"H Huang","year":"2023","unstructured":"Huang H, Bu X, Pan H, Yang S, Cheng W, Shubhra QTH, Ma N. Estimated pulse wave velocity is associated with all-cause and cardio-cerebrovascular disease mortality in stroke population: results from NHANES (2003\u20132014). Front Cardiovasc Med. 2023;10:1140160.","journal-title":"Front Cardiovasc Med"},{"key":"26316_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/hep.29113","volume":"66","author":"A Unalp-Arida","year":"2017","unstructured":"Unalp-Arida A, Ruhl CE. Liver fibrosis scores predict liver disease mortality in the united States population. Hepatology. 2017;66:84\u201395.","journal-title":"Hepatology"},{"key":"26316_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/liv.14669","volume":"41","author":"J Lee","year":"2021","unstructured":"Lee J, Vali Y, Boursier J, Spijker R, Anstee QM, Bossuyt PM, Zafarmand MH. Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review. Liver Int. 2021;41:261\u201370.","journal-title":"Liver Int"},{"key":"26316_CR22","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.cgh.2018.11.030","volume":"17","author":"H Hagstr\u00f6m","year":"2019","unstructured":"Hagstr\u00f6m H, Nasr P, Ekstedt M, St\u00e5l P, Hultcrantz R, Kechagias S. Accuracy of noninvasive scoring systems in assessing risk of death and liver-Related endpoints in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2019;17:1148\u2013e11561144.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"26316_CR23","doi-asserted-by":"publisher","first-page":"155666","DOI":"10.1016\/j.metabol.2023.155666","volume":"147","author":"M Kouvari","year":"2023","unstructured":"Kouvari M, Valenzuela-Vallejo L, Guatibonza-Garcia V, Polyzos SA, Deng Y, Kokkorakis M, Agraz M, Mylonakis SC, Katsarou A, Verrastro O, et al. Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: results from a large multi-center study. Metabolism. 2023;147:155666.","journal-title":"Metabolism"},{"key":"26316_CR24","doi-asserted-by":"publisher","first-page":"5753","DOI":"10.3748\/wjg.v27.i34.5753","volume":"27","author":"YL Wu","year":"2021","unstructured":"Wu YL, Kumar R, Wang MF, Singh M, Huang JF, Zhu YY, Lin S. Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease. World J Gastroenterol. 2021;27:5753\u201363.","journal-title":"World J Gastroenterol"},{"key":"26316_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.14218\/JCTH.2021.00311","volume":"10","author":"X Chen","year":"2022","unstructured":"Chen X, Goh GB, Huang J, Wu Y, Wang M, Kumar R, Lin S, Zhu Y. Validation of Non-invasive fibrosis scores for predicting advanced fibrosis in Metabolic-associated fatty liver disease. J Clin Transl Hepatol. 2022;10:589\u201394.","journal-title":"J Clin Transl Hepatol"},{"key":"26316_CR26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jhep.2020.06.007","volume":"73","author":"H Hagstr\u00f6m","year":"2020","unstructured":"Hagstr\u00f6m H, Talb\u00e4ck M, Andreasson A, Walldius G, Hammar N. Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease. J Hepatol. 2020;73:1023\u20139.","journal-title":"J Hepatol"},{"key":"26316_CR27","doi-asserted-by":"publisher","first-page":"101127","DOI":"10.1016\/j.jhepr.2024.101127","volume":"6","author":"P Sripongpun","year":"2024","unstructured":"Sripongpun P, Kaewdech A, Udompap P, Kim WR. Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score. JHEP Rep. 2024;6:101127.","journal-title":"JHEP Rep"},{"key":"26316_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/liv.15718","volume":"44","author":"G Li","year":"2024","unstructured":"Li G, Lin H, Sripongpun P, Liang LY, Zhang X, Wong VWS, Wong GLH, Kim WR, Yip TCF. Diagnostic and prognostic performance of the SAFE score in non-alcoholic fatty liver disease. Liver Int. 2024;44:15\u201326.","journal-title":"Liver Int"},{"key":"26316_CR29","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"EASL-EASD-EASO","year":"2016","unstructured":"EASL-EASD-EASO. Clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388\u2013402.","journal-title":"J Hepatol"},{"key":"26316_CR30","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3748\/wjg.v19.i8.1219","volume":"19","author":"S Treeprasertsuk","year":"2013","unstructured":"Treeprasertsuk S, Bj\u00f6rnsson E, Enders F, Suwanwalaikorn S, Lindor KD. NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients. World J Gastroenterol. 2013;19:1219\u201329.","journal-title":"World J Gastroenterol"},{"key":"26316_CR31","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/hep.26156","volume":"57","author":"D Kim","year":"2013","unstructured":"Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the united States. Hepatology. 2013;57:1357\u201365.","journal-title":"Hepatology"},{"key":"26316_CR32","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jhep.2021.05.008","volume":"75","author":"R Younes","year":"2021","unstructured":"Younes R, Caviglia GP, Govaere O, Rosso C, Armandi A, Sanavia T, Pennisi G, Liguori A, Francione P, Gallego-Dur\u00e1n R, et al. Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease. J Hepatol. 2021;75:786\u201394.","journal-title":"J Hepatol"},{"key":"26316_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/hepr.13570","volume":"51","author":"X Mao","year":"2021","unstructured":"Mao X, Liu Z, Shi O, Yu K, Jiang Y, Jin L, Zhang T, Chen X. Non-invasive fibrosis markers are associated with mortality risk in both general populations and non-alcoholic fatty liver disease patients. Hepatol Res. 2021;51:90\u2013101.","journal-title":"Hepatol Res"},{"key":"26316_CR34","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/apt.12963","volume":"40","author":"L Fedchuk","year":"2014","unstructured":"Fedchuk L, Nascimbeni F, Pais R, Charlotte F, Housset C, Ratziu V. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2014;40:1209\u201322.","journal-title":"Aliment Pharmacol Ther"},{"key":"26316_CR35","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.clnu.2024.02.006","volume":"43","author":"M Kouvari","year":"2024","unstructured":"Kouvari M, Chrysohoou C, Damigou E, Barkas F, Kravvariti E, Liberopoulos E, Tsioufis C, Sfikakis PP, Pitsavos C, Panagiotakos D, Mantzoros CS. Non-invasive tools for liver steatosis and steatohepatitis predict incidence of diabetes, cardiovascular disease and mortality 20 years later: the ATTICA cohort study (2002\u20132022). Clin Nutr. 2024;43:900\u20138.","journal-title":"Clin Nutr"},{"key":"26316_CR36","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","volume":"80","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Paik JM, Stepanova M, Ong J, Alqahtani S, Henry L. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease. J Hepatol. 2024;80:694\u2013701.","journal-title":"J Hepatol"},{"key":"26316_CR37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73:691\u2013702.","journal-title":"Gut"},{"key":"26316_CR38","doi-asserted-by":"crossref","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic Dysfunction-Associated steatotic liver disease. Clin Mol Hepatol. 2024;30(1):16-36.","DOI":"10.3350\/cmh.2024.0360"},{"key":"26316_CR39","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","volume":"75","author":"D Kim","year":"2021","unstructured":"Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the united States. J Hepatol. 2021;75:1284\u201391.","journal-title":"J Hepatol"},{"key":"26316_CR40","first-page":"1779","volume":"38","author":"NWS Chew","year":"2022","unstructured":"Chew NWS, Ng CH, Chan KE, Chee D, Syn N, Tamaki N, Muthiah M, Noureddin M. FIB-4 predicts MACE and cardiovascular mortality in patients with nonalcoholic fatty liver disease. Can J Cardiol. 2022;38:1779\u201380.","journal-title":"Can J Cardiol"},{"key":"26316_CR41","doi-asserted-by":"publisher","first-page":"100780","DOI":"10.1016\/j.lanepe.2023.100780","volume":"36","author":"QM Anstee","year":"2024","unstructured":"Anstee QM, Berentzen TL, Nitze LM, Jara M, Jensen AB, Kj\u00e6r MS, Mangla KK, Tarp JM, Khunti K. Prognostic utility of Fibrosis-4 index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and\/or type 2 diabetes: a longitudinal cohort study. Lancet Reg Health Eur. 2024;36:100780.","journal-title":"Lancet Reg Health Eur"},{"key":"26316_CR42","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.pcad.2013.09.002","volume":"56","author":"VW Barry","year":"2014","unstructured":"Barry VW, Baruth M, Beets MW, Durstine JL, Liu J, Blair SN. Fitness vs. fatness on all-cause mortality: a meta-analysis. Prog Cardiovasc Dis. 2014;56:382\u201390.","journal-title":"Prog Cardiovasc Dis"},{"key":"26316_CR43","first-page":"195","volume":"1","author":"VS Joshi","year":"1964","unstructured":"Joshi VS. ONE SECOND NEEDLE LIVER BIOPSY. Indian Pediatr. 1964;1:195\u20138.","journal-title":"Indian Pediatr"},{"key":"26316_CR44","doi-asserted-by":"crossref","unstructured":"Calzadilla Bertot L, Adams LA. The natural course of Non-Alcoholic fatty liver disease. Int J Mol Sci. 2016;20;17(5):774.","DOI":"10.3390\/ijms17050774"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-26316-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26316-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26316-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:08:11Z","timestamp":1771434491000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-26316-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["26316"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-26316-5","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent, and the study procedures were approved by the National Center for Health Statistics Research Ethics Review Board (Protocol Numbers: Protocol #98\u201312, Protocol #2005\u201306, and Protocol #2011\u201317).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"617"}}